You are here

amlitelimab

Sanofi's 'daughter of Dupixent' heads to phase 3 in asthma

Pharmaphorum

Tue, 04/15/25 - 09:53 am

clinical trials

Sanofi, facing skeptical investors, predicts $5B sales for 3 drugs, names 9 more blockbusters

Fierce Biotech

Thu, 12/7/23 - 10:19 am

Sanofi's $1.1B eczema drug hits midphase goal, spurring talk of phase 3 and new indications

Fierce Biotech

Tue, 06/27/23 - 10:09 am

clinical trials